Literature DB >> 10068895

The impact of preoperative tracheotomy on T3 transglottic carcinomas of the larynx.

J F Carrillo1, M Frías-Mendívil, C Lopez-Graniel, A I Beitia, F J Ochoa-Carrillo.   

Abstract

To evaluate the impact of the practice of a preoperative tracheotomy and different prognostic factors reported in the literature in patients with transglottic carcinoma of the larynx, a retrospective study was performed in the Instituto Nacional de Cancerologia, Mexico City. In all, 90 cases with T3 transglottic squamous cell carcinoma requiring a total laryngectomy as primary treatment were studied. Prognostic factors such as the Karnofsky index, tumor differentiation, surgical margins and preoperative tracheotomy were analyzed by a Cox's proportional hazards model. The Kaplan-Meier method and log rank test were used to evaluate the disease-free intervals and survival curves. Thirty-two patients had preoperative tracheotomies, while 58 did not. Eighty percent of the patients in the non-preoperative tracheotomy group were alive after 5 years versus 20% of those with preoperative tracheotomies (P < 0.001). Although possibly controversial, our findings indicate that a pretreatment tracheotomy should be avoided in T3 transglottic obstructive lesions. In patients with these lesions and a subglottic extension < or = 3 cm we recommend an emergency total laryngectomy when possible to increase survival and decrease surgical morbidity.

Entities:  

Mesh:

Year:  1999        PMID: 10068895     DOI: 10.1007/s004050050120

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  3 in total

1.  Clinical and molecular prognostic factors in operable laryngeal cancer.

Authors:  Konstantinos Vlachtsis; Angelos Nikolaou; Konstantinos Markou; George Fountzilas; Ioannis Daniilidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-01       Impact factor: 2.503

2.  Preoperative Tracheostomy Is Associated with Poor Disease-Free Survival in Recurrent Laryngeal Cancer.

Authors:  Andrew C Birkeland; Andrew J Rosko; Lauren Beesley; Emily Bellile; Steven B Chinn; Andrew G Shuman; Mark E Prince; Gregory T Wolf; Carol R Bradford; J Chad Brenner; Matthew E Spector
Journal:  Otolaryngol Head Neck Surg       Date:  2017-06-06       Impact factor: 3.497

3.  Induction chemotherapy in locally advanced pharyngolaryngeal cancers with stridor: is it feasible and safe?

Authors:  Vijay Maruti Patil; Vanita Noronha; Amit Joshi; Vamshi Muddu; Bhavesh Poladia; Bharat Chauhan; Kumar Prabhash; Devendra Arvind Chaukar; Pankaj Chatturvedi; Gouri Pantvaidya; Shashikant Juvekar; Anil D'cruz
Journal:  Chemother Res Pract       Date:  2012-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.